HK
Therapeutic Areas
Myomo Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MyoPro 2+ Series | Upper limb paralysis/weakness (Stroke, BPI, TBI, SCI, CP) | Commercial |
| Clinical Evidence Generation | Chronic Stroke, Traumatic Brain Injury, Brachial Plexus Injury | Post-Market Studies |